By www.reliableresearchiq.com
Global Antihemophilic Factor (Recombinant) Market Size, Status And Forecast 2024-2031 Story
100
$ 3900
Antihemophilic Factor (Recombinant) Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Takeda Bayer CSL Pfizer Biogen Octapharma NovoNordisk